Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lavender oil WS 1265 for restlessness and sleep disturbances
2004-003975-35Phase 3Completed
- Sponsor
- Schwabe Group
- Start
- Dec 2004
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Restlessness and sleep disorder comparing Lavender oil WS 1265 with Placebo (2 arms). Primary endpoint: Change in HAM-A total score from baseline to week 10. Started Dec 2004; status: completed.
02
Drugs
Silexan
03
Conditions
Restlessnesssleep disorder
Beyond the preview
Go deeper on 2004-003975-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003975-35.